anna mccollister-slipp - diabetesmine innovation summit 2013

14
Something seems to be missing here…? Data and Device Interoperability” Anna McCollister-Slipp Co-Founder Galileo Analytics Type 1 diabetes patient for 28 years [email protected] @annamcslipp

Upload: amy-tenderich

Post on 07-May-2015

2.201 views

Category:

Health & Medicine


1 download

DESCRIPTION

Anna McCollister-Slipp, data entreprenuer and longtime type 1 diabetes patient advocate, presents at the 2013 DiabetesMine Innovation Summit held Nov. 15 at Stanford School of Medicine. She issues a call to action for patients.

TRANSCRIPT

Page 1: Anna McCollister-Slipp - DiabetesMine Innovation Summit 2013

Something seems to be missing here…?

“Data and Device Interoperability” 

Anna McCollister-Slipp Co-Founder

Galileo Analytics Type 1 diabetes patient for 28 years

[email protected] @annamcslipp

Page 2: Anna McCollister-Slipp - DiabetesMine Innovation Summit 2013

…This is now‣ Dexcom Platinum G4

‣ No apple software ‣ No connection with meters ‣ No connection with pumps ‣ Connection with pumps keeps data

locked in system

‣ Medtronic Carelink ‣ No connection with other devices,

apps ‣ Just supported Apple in 2011

‣ Tandem t-slim pump ‣ No connection with CGM or meter

‣ Sanofi iBG Star ‣ Doesn’t work with iPhone 5 ‣ No interaction with pumps, cgms

‣ Telcare ‣ No connection with other devices

‣ Omnipod ‣ No apple software ‣ No connection with other devices

That was then...No Real Change! - Dexcom - No apple software

- Partnerships w/ Animas, Tandem

- Animas - Export data to .XML/.CSV

- Omnipod - Canceled Dexcom

partnership

- No Apple software

- Medtronic Carelink - Still closed system

- iBG Star and Telcare - No change

Page 3: Anna McCollister-Slipp - DiabetesMine Innovation Summit 2013

$150M in VC Funds in

1H 2013

$718m in Revenue in

2012

43,689…health, fitness, medical

14,243… patient journey

Health apps big business

8,786… focused on prevention

2,222…relevant after diagnosis

FAILmHealth for everything… but patients

mHealth is ‘Hot’

Page 4: Anna McCollister-Slipp - DiabetesMine Innovation Summit 2013

Long-use CGMs

Biometric Patches

Pill trackers

Orthopedic

Neuro

Sensors Proliferating

Cardiac

Med Devices increasingly

sophisticated

Data-Generation on the Rise

Page 5: Anna McCollister-Slipp - DiabetesMine Innovation Summit 2013

Grants and Challenges

$1.2 billion in 2012

Incentive payments $27

billion

$493 million in Q1 2013

HITECH

Open Data and healthdata.gov

ARRA

Private Investments

Government Incentives

HIT Explosion

Page 6: Anna McCollister-Slipp - DiabetesMine Innovation Summit 2013

PCORI

Sentinel

Private Insurers

AHRQ/NQF

ACOs

MDEpiNetSafety and

Surveillance

Outcomes Development

Big Buzz about

Evidence

Page 7: Anna McCollister-Slipp - DiabetesMine Innovation Summit 2013

FCC

FDASIAmHealth Guidance Document

Continua Health

Industry Coalitions

AAMI

FDA Recognition of

Interoperability Standards

Blue Button

Meaningful Use

Page 8: Anna McCollister-Slipp - DiabetesMine Innovation Summit 2013

mHealth is ‘Hot’

Health apps big business

mHealth for everything… but patients

Med Devices increasingly

sophisticated

Data-Generation on the Rise

Sensors Proliferating

HIT Explosion

Government Incentives

Private Investments

Big Buzz about

Evidence

Outcomes Development

Safety and Surveillance

FCC

FDASIAmHealth Guidance Document

Continua Health

Industry Coalitions

AAMI Blue Button

FDA Recognition of

Interoperability Standards

Patients!

Meaningful Use

Page 9: Anna McCollister-Slipp - DiabetesMine Innovation Summit 2013

ADA

ACAWorkplace

Discrimination

Artificial Pancreas

Special Diabetes Project

National Health Council

Patients Like Me

Society of Participatory

Medicine

JDRF

Diabetes Groups

Everybody Else

Hackers

DOC Researchers

Diabetes Community

Patients!!

Page 10: Anna McCollister-Slipp - DiabetesMine Innovation Summit 2013

Really...?‣ Nobody links data from other

medical condition devices

‣ Nobody connects with other apps

‣ Nobody releases their data API for external development

‣ Nobody seems willing to lead

Page 11: Anna McCollister-Slipp - DiabetesMine Innovation Summit 2013

Who Needs to Lead...?

FDA

IndustryUs

Page 12: Anna McCollister-Slipp - DiabetesMine Innovation Summit 2013

We need to lead!‣ Organize to affect real change

‣ Articulate our needs, demands and plot the way forward

‣ Create pressure for action now! • Government

- Give forward-thinking agency, Hill staff political cover • Industry

- Support internal advocates through pressuring C suite

‣ Be the patient voice with media • Give reporters, bloggers a reason to care

‣ Policy forums • Articulate the benefits of empowerment through innovation

Page 13: Anna McCollister-Slipp - DiabetesMine Innovation Summit 2013

This is our disease

These are our issues

Others will follow… but we need to lead the way.

We know them better than anybody

Page 14: Anna McCollister-Slipp - DiabetesMine Innovation Summit 2013

Let’s make something happen!

Anna McCollister-Slipp Co-Founder

Galileo Analytics Type 1 diabetes patient for 28 years

[email protected] @annamcslipp